Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

• Rebecca Hein ,

  * E-mail: rebecca.hein@uk-koeln.de (RH); alisond@srl.cam.ac.uk (AD)

  Affiliations Unit of Genetic Epidemiology, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, PMV (Primärmedizinische Versorgung) Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany

  ⨯
• Melanie Maranian,

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• John L. Hopper,

  Affiliation Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia

  ⨯
• Miroslaw K. Kapuscinski,

  Affiliation Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia

  ⨯
• Melissa C. Southey,

  Affiliation Department of Pathology, The University of Melbourne, Melbourne, Australia

  ⨯
• Daniel J. Park,

  Affiliation Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia

  ⨯
• Marjanka K. Schmidt,

  Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands

  ⨯
• Annegien Broeks,

  Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands

  ⨯
• Frans B. L. Hogervorst,

  Affiliation Family Cancer Clinic, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

  ⨯
• H. Bas Bueno-de-Mesquit,

  Affiliation National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Kenneth R. Muir,

  Affiliation Health Sciences Research Institute, Warwick Medical School, Warwick University, Coventry, Warwick, United Kingdom

  ⨯
• Artitaya Lophatananon,

  Affiliation Health Sciences Research Institute, Warwick Medical School, Warwick University, Coventry, Warwick, United Kingdom

  ⨯
• Suthee Rattanamongkongul,

  Affiliation Department of Preventive Medicine, Srinakhrainwirot University, Ongkharak, Nakhon Nayok, Thailand

  ⨯
• Puttisak Puttawibul,

  Affiliation Department of Surgery, Medical School, Prince Songkla University, Songkla, Thailand

  ⨯
• Peter A. Fasching,

  Affiliations University Breast Center, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America

  ⨯
• Alexander Hein,

  Affiliation University Breast Center, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany

  ⨯
• Arif B. Ekici,

  Affiliation Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany

  ⨯
• Matthias W. Beckmann,

  Affiliation University Breast Center, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany

  ⨯
• Olivia Fletcher,

  Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Nichola Johnson,

  Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Isabel dos Santos Silva,

  Affiliation Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Julian Peto,

  Affiliation Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Elinor Sawyer,

  Affiliation Division of Cancer Studies, National Institute for Health Research Comprehensive Biomedical Research Centre, Guy’s & St. Thomas’ National Health Service Foundation Trust in partnership with King’s College London, London, United Kingdom

  ⨯
• Ian Tomlinson,

  Affiliations Welcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom, Oxford National Institute for Health Research Comprehensive Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Michael Kerin,

  Affiliation Clinical Science Institute. University Hospital Galway, Galway, Ireland

  ⨯
• Nicola Miller,

  Affiliation Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Frederick Marmee,

  Affiliations Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany

  ⨯
• Andreas Schneeweiss,

  Affiliations Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany

  ⨯
• Christof Sohn,

  Affiliation Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Barbara Burwinkel,

  Affiliations Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany, Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Pascal Guénel,

  Affiliations Environmental Epidemiology of Cancer, U1018, CESP (Center for Research in Epidemiology and Population Health), Inserm (National Institute of Health and Medical Research), Villejuif, France, Unité mixte de recherche 1018, University Paris-Sud, Villejuif, France

  ⨯
• Emilie Cordina-Duverger,

  Affiliations Environmental Epidemiology of Cancer, U1018, CESP (Center for Research in Epidemiology and Population Health), Inserm (National Institute of Health and Medical Research), Villejuif, France, Unité mixte de recherche 1018, University Paris-Sud, Villejuif, France

  ⨯
• Florence Menegaux,

  Affiliations Environmental Epidemiology of Cancer, U1018, CESP (Center for Research in Epidemiology and Population Health), Inserm (National Institute of Health and Medical Research), Villejuif, France, Unité mixte de recherche 1018, University Paris-Sud, Villejuif, France

  ⨯
• Thérèse Truong,

  Affiliations Environmental Epidemiology of Cancer, U1018, CESP (Center for Research in Epidemiology and Population Health), Inserm (National Institute of Health and Medical Research), Villejuif, France, Unité mixte de recherche 1018, University Paris-Sud, Villejuif, France

  ⨯
• Stig E. Bojesen,

  Affiliation Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev University Hospital, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Børge G. Nordestgaard,

  Affiliation Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev University Hospital, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Henrik Flyger,

  Affiliation Department of Breast Surgery, Herlev University Hospital, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Roger L. Milne,

  Affiliation Genetic & Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Jose Ignacio Arias Perez,

  Affiliation Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain

  ⨯
• M. Pilar Zamora,

  Affiliation Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain

  ⨯
• Javier Benítez,

  Affiliation Cancer Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Hoda Anton-Culver,

  Affiliation Department of Epidemiology, University of California Irvine, Irvine, California, United States of America

  ⨯
• Argyrios Ziogas,

  Affiliation Department of Epidemiology, University of California Irvine, Irvine, California, United States of America

  ⨯
• Leslie Bernstein,

  Affiliation Department of Population Sciences, City of Hope, Duarte, California, United States of America

  ⨯
• Christina A. Clarke,

  Affiliation Cancer Prevention Institute of California, Fremont, California, United States of America

  ⨯
• Hermann Brenner,

  Affiliation Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Heiko Müller,

  Affiliation Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Volker Arndt,

  Affiliation Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Christa Stegmaier,

  Affiliation Saarland Cancer Registry, Saarbrücken, Germany

  ⨯
• Nazneen Rahman,

  Affiliation Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Sheila Seal,

  Affiliation Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Clare Turnbull,

  Affiliation Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Anthony Renwick,

  Affiliation Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Alfons Meindl,

  Affiliation Division of Gynecology and Obstetrics, Klinikum rechts der Isar at the Technical University Munich, Munich, Germany

  ⨯
• Sarah Schott,

  Affiliation Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Claus R. Bartram,

  Affiliation Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany

  ⨯
• Rita K. Schmutzler,

  Affiliation Center for Familial Breast and Ovarian Cancer and Center of Integrated Oncology (CIO), University Hospital, Cologne, Germany

  ⨯
• Hiltrud Brauch,

  Affiliation Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, University of Tübingen, Tübingen, Germany

  ⨯
• Ute Hamann,

  Affiliation Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany

  ⨯
• Yon-Dschun Ko,

  Affiliation Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany

  ⨯
• The GENICA Network,

  Affiliations Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, University of Tübingen, Tübingen, Germany, Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany, Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany, Institute of Pathology, University of Bonn, Bonn, Germany, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany

  ⨯
• Shan Wang-Gohrke,

  Affiliation Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany

  ⨯
• Thilo Dörk,

  Affiliation Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany

  ⨯
• Peter Schürmann,

  Affiliation Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany

  ⨯
• Johann H. Karstens,

  Affiliation Clinics of Radiation Oncology, Hannover Medical School, Hannover, Germany

  ⨯
• Peter Hillemanns,

  Affiliation Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany

  ⨯
• Heli Nevanlinna,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Tuomas Heikkinen,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Kristiina Aittomäki,

  Affiliation Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Carl Blomqvist,

  Affiliation Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Natalia V. Bogdanova,

  Affiliation Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany, Clinics of Radiation Oncology, Hannover Medical School, Hannover, Germany

  ⨯
• Iosif V. Zalutsky,

  Affiliation N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus

  ⨯
• Natalia N. Antonenkova,

  Affiliation N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus

  ⨯
• Marina Bermisheva,

  Affiliation Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia

  ⨯
• Darya Prokovieva,

  Affiliation Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia

  ⨯
• Albina Farahtdinova,

  Affiliation Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia

  ⨯
• Elza Khusnutdinova,

  Affiliation Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia

  ⨯
• Annika Lindblom,

  Affiliation Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Sara Margolin,

  Affiliation Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Arto Mannermaa,

  Affiliations Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden, Clinics of Radiation Oncology, Hannover Medical School, Hannover, Germany, Biocenter Kuopio, Kuopio University Hospital, Kuopio, Finland, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland

  ⨯
• Vesa Kataja,

  Affiliations Biocenter Kuopio, Kuopio University Hospital, Kuopio, Finland, School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland, Department of Oncology, Kuopio University Hospital, Kuopio, Finland

  ⨯
• Veli-Matti Kosma,

  Affiliations School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Biocenter Kuopio, Kuopio University Hospital, Kuopio, Finland, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland

  ⨯
• Jaana Hartikainen,

  Affiliations School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Biocenter Kuopio, Kuopio University Hospital, Kuopio, Finland, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland

  ⨯
• Xiaoqing Chen,

  Affiliation Cancer Division, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Jonathan Beesley,

  Affiliation Cancer Division, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• kConFab Investigators,

  Affiliation Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer [kConFab], Peter MacCallum Cancer Center, Melbourne, Australia

  ⨯
• AOCS Group,

  Affiliation Australian Ovarian Cancer Study [AOCS], Peter MacCallum Cancer Center, Melbourne, Australia

  ⨯
• Diether Lambrechts,

  Affiliation Vesalius Research Center (VRC), Vesalius Research Center, Leuven, Belgium; Vesalius Research Center (VRC), Katholieke Universiteit (KU) Leuven, Leuven, Belgium

  ⨯
• Hui Zhao,

  Affiliation Vesalius Research Center (VRC), Vesalius Research Center, Leuven, Belgium; Vesalius Research Center (VRC), Katholieke Universiteit (KU) Leuven, Leuven, Belgium

  ⨯
• Patrick Neven,

  Affiliation Multidisciplinary Breast Center, University Hospital Gasthuisberg, Leuven, Belgium

  ⨯
• Hans Wildiers,

  Affiliation Multidisciplinary Breast Center, University Hospital Gasthuisberg, Leuven, Belgium

  ⨯
• Stefan Nickels,

  Affiliation Unit of Genetic Epidemiology, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Dieter Flesch-Janys,

  Affiliation Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany

  ⨯
• Paolo Radice,

  Affiliations Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy, Fondazione Istituto FIRC (Fondazione Italiana per la Ricerca sul Cancro) Di Oncologia Molecolare (IFOM), Milan, Italy

  ⨯
• Paolo Peterlongo,

  Affiliations Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy, Fondazione Istituto FIRC (Fondazione Italiana per la Ricerca sul Cancro) Di Oncologia Molecolare (IFOM), Milan, Italy

  ⨯
• Siranoush Manoukian,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Instituto di Recuvero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Monica Barile,

  Affiliation Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy

  ⨯
• Fergus J. Couch,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Janet E. Olson,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Xianshu Wang,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Zachary Fredericksen,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Graham G. Giles,

  Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia

  ⨯
• Laura Baglietto,

  Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia

  ⨯
• Catriona A. McLean,

  Affiliation Department of Anatomical Pathology, The Alfred Hospital, Melbourne, Australia

  ⨯
• Gianluca Severi,

  Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia

  ⨯
• Kenneth Offit,

  Affiliation Clinical Genetics Service, Dept. of Medicine and Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Mark Robson,

  Affiliation Clinical Genetics Service, Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Mia M. Gaudet,

  Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America

  ⨯
• Joseph Vijai,

  Affiliation Clinical Genetics Service, Dept. of Medicine and Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Grethe Grenaker Alnæs,

  Affiliation Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway

  ⨯
• Vessela Kristensen,

  Affiliations Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway, Faculty of Medicine (Faculty Division Ahus), University of Oslo, Oslo, Norway

  ⨯
• Anne-Lise Børresen-Dale,

  Affiliations Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway, Faculty of Medicine (Faculty Division Ahus), University of Oslo, Oslo, Norway

  ⨯
• Esther M. John,

  Affiliations Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Alexander Miron,

  Affiliation Deptartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Robert Winqvist,

  Affiliation Laboratory of Cancer Genetics, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland

  ⨯
• Katri Pylkäs,

  Affiliation Laboratory of Cancer Genetics, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland

  ⨯
• Arja Jukkola-Vuorinen,

  Affiliation Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland

  ⨯
• Mervi Grip,

  Affiliation Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland

  ⨯
• Irene L. Andrulis,

  Affiliations Ontario Cancer Genetics Network, Cancer Care Ontario, Toronto, Ontario, Canada, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Julia A. Knight,

  Affiliations Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Gord Glendon,

  Affiliation Ontario Cancer Genetics Network, Cancer Care Ontario, Toronto, Ontario, Canada

  ⨯
• Anna Marie Mulligan,

  Affiliations Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Department of Laboratory Medicine, and the Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, Ontario, Canada

  ⨯
• Jonine D. Figueroa,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Montserrat García-Closas,

  Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America, Sections of Epidemiology and Genetics, Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom

  ⨯
• Jolanta Lissowska,

  Affiliation Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland

  ⨯
• Mark E. Sherman,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Maartje Hooning,

  Affiliation Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• John W. M. Martens,

  Affiliation Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Caroline Seynaeve,

  Affiliation Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Margriet Collée,

  Affiliation Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Per Hall,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Keith Humpreys,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Kamila Czene,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Jianjun Liu,

  Affiliation Population Genetics, Genome Institute of Singapore, Singapore, Republic of Singapore

  ⨯
• Angela Cox,

  Affiliation Institute for Cancer Studies, Department of Oncology, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Ian W. Brock,

  Affiliation Institute for Cancer Studies, Department of Oncology, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Simon S. Cross,

  Affiliation Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Malcolm W. R. Reed,

  Affiliation Academic Unit of Surgical Oncology, Department of Oncology, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Shahana Ahmed,

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Maya Ghoussaini,

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Paul DP. Pharoah,

  Affiliations Department of Oncology, University of Cambridge, Cambridge, United Kingdom, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Daehee Kang,

  Affiliation Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Keun-Young Yoo,

  Affiliation Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Dong-Young Noh,

  Affiliation Department of Surgery, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Anna Jakubowska,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Katarzyna Jaworska,

  Affiliations Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland

  ⨯
• Katarzyna Durda,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Elżbieta Złowocka,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Suleeporn Sangrajrang,

  Affiliation Molecular Epidemiology Unit, National Cancer Institute, Bangkok, Thailand

  ⨯
• Valerie Gaborieau,

  Affiliation Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Paul Brennan,

  Affiliation Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• James McKay,

  Affiliation Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Chen-Yang Shen,

  Affiliations Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Taiwan Biobank, Taipei, Taiwan

  ⨯
• Jyh-Cherng Yu,

  Affiliation Department of Surgery, Tri-Service General Hospital, Taipei, Taiwan

  ⨯
• Huan-Ming Hsu,

  Affiliation Department of Surgery, Tri-Service General Hospital, Taipei, Taiwan

  ⨯
• Ming-Feng Hou,

  Affiliation Cancer Center and Department of Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

  ⨯
• Nick Orr,

  Affiliation The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Minouk Schoemaker,

  Affiliation Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Alan Ashworth,

  Affiliation The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Anthony Swerdlow,

  Affiliation Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Amy Trentham-Dietz,

  Affiliation University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America

  ⨯
• Polly A. Newcomb,

  Affiliations University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States of America, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Linda Titus,

  Affiliation Department of Community & Family Medicine, Department of Pediatrics, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire, United States of America

  ⨯
• Kathleen M. Egan,

  Affiliation Division of Population Sciences, Moffitt Cancer Center & Research Institute, Tampa, Florida, United States of America

  ⨯
• Georgia Chenevix-Trench,

  Affiliation Cancer Division, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Antonis C. Antoniou,

  Affiliation Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Manjeet K. Humphreys,

  Affiliation Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Jonathan Morrison,

  Affiliation Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Jenny Chang-Claude,

  Affiliation Unit of Genetic Epidemiology, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Douglas F. Easton,

  Affiliation Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
•  [ ... ],
• Alison M. Dunning

  * E-mail: rebecca.hein@uk-koeln.de (RH); alisond@srl.cam.ac.uk (AD)

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• [ view all ]
• [ view less ]